e-health technologies are already today starting to revolutionize the therapeutic processes and patients management paradigm. Unfortunately, e-health developers are very often uncomfortable with the regulatory maze they have to navigate into (or are simply unaware of it) until their e-health products could be placed on the European market.

Key learning objectives:

  • European regulatory framework applicable to m-health technologies
  • m-health products development and evaluation
  • Critical regulatory challenges for the EU market

Christophe Amiel, Senior Director at VCLS, will share his experience on these innovative m-health technologies and the associated development hurdles. He will illustrate critical matters related to the regulatory environment relevant to e-health products and how to best overcome these challenges for derisking market launch in Europe.

Christophe_Amiel

Christophe Amiel, heads the design and implementation of regulatory strategy as Senior Director within Voisin Consulting Life Sciences for medical devices (including in vitro diagnostics), e-health products, as well as combination products (drug-device association) including activities related to Clinical Trials Application and vigilance.

View profile

Download the full Webinar now